Furthermore, in resting primary CGD cells, the NFκB inhibitor IκB was phosphorylated and degraded, and correspondingly, more of the p50 subunit of NFκB was localized in the nucleus (7). This evidence concerns the gene NFKB1 and chronic granulomatous disease.